Highly leveraged private equity (PE) deals are expected to come under tight scrutiny by the UK Competition and Markets Authority (CMA) in a merger divestiture process, where the agency will want to ensure that remedy takers can execute business plans, lawyers told Unquote sister publication PaRR.